Document Type
Article
Publication Date
2013
Abstract
The Supreme Court decision in Myriad Genetics struck down the patenting of human genomic DNA. What will this mean for genetic testing and medicine, more broadly?
Recommended Citation
173 JAMA Internal Medicine 1569, Sept. 2013
Included in
Food and Drug Law Commons, Health Law and Policy Commons, Science and Technology Law Commons